MedTrace Logo

Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma

NCT01531608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-12-15

No results posted yet for this study

Summary

This is a single-institution study seeking to evaluate if mobile gamma camera imaging can be used independent of standard fixed gamma camera imaging in patients undergoing sentinel node biopsy for melanoma.

Conditions

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • Craig L Slingluff, MD · University of Virginia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01531608 on ClinicalTrials.gov